atypical ductal breast hyperplasia
Showing 1 - 25 of >10,000
Atypical Ductal Hyperplasia, Ductal Carcinoma in Situ Trial in Milan (Vacuum-assisted excisional biopsy)
Recruiting
- Atypical Ductal Hyperplasia
- Ductal Carcinoma in Situ
- Vacuum-assisted excisional biopsy
-
Milan, ItalyBreast Imaging Division, Radiology Department, IEO European Inst
Jun 27, 2023
Molecular Analysis of the Sloane Project
Enrolling by invitation
- DCIS
- +3 more
-
London, United KingdomKing's College London
May 11, 2023
Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Ductal Carcinoma In Situ Trial in Houston
Completed
- Breast Atypical Ductal Hyperplasia
- +4 more
- Bexarotene
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2022
Standard Breast Cancer Risk Assessment for African American and
Not yet recruiting
- Breast Atypical Ductal Hyperplasia
- +3 more
- Biospecimen Collection
- +2 more
-
Jacksonville, FloridaMayo Clinic in Florida
Feb 22, 2023
Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in United States (Acolbifene Hydrochloride,
Not yet recruiting
- Breast Atypical Hyperplasia
- +3 more
- Acolbifene Hydrochloride
- +4 more
-
Duarte, California
- +3 more
Jul 11, 2023
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
Not yet recruiting
- Breast Atypical Ductal Hyperplasia
- +4 more
- Follow-Up
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 16, 2021
Atypical Hyperplasia, Lobular Carcinoma in Situ Trial in Rochester (Tamoxifen, Topical 4-OHT( 4-hydroxytamoxifen)gel 2 mg/each
Recruiting
- Atypical Hyperplasia
- Lobular Carcinoma in Situ
- Tamoxifen
- +2 more
-
Evanston, Illinois
- +1 more
Jan 20, 2023
Atypical Hyperplasia of the Breast, Lobular Breast Carcinoma In Situ, Pleomorphic Lobular Breast Carcinoma In Situ Trial in
Recruiting
- Atypical Hyperplasia of the Breast
- +2 more
- Cancer Educational Materials
- +3 more
-
Costa Mesa, California
- +48 more
Jan 9, 2023
High-Risk Breast Duct Epithelium
Completed
- Breast Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 8, 2023
Contrast-Enhanced MRI for Characterization of Ductal Carcinoma
Recruiting
- Breast Cancer
- contrast-enhanced magnetic resonance imaging
- Gadavist
-
San Francisco, CaliforniaUniversity of California, San Francisco
Nov 30, 2021
Atypical Ductal Breast Hyperplasia, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Columbus (curcumin, Biomarker analysis,
Completed
- Atypical Ductal Breast Hyperplasia
- +4 more
- curcumin
- +3 more
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Aug 29, 2019
Atypia and Subsequent Development of Cancer in England
Enrolling by invitation
- Breast Cancer
- A diagnosis of atypia as part of the English screening programme
-
Coventry, Warwickshire, United KingdomUnivesity of Warwick
May 30, 2022
Atypical Ductal Hyperplasia Trial in Boston (Contrast enhanced mammography)
Terminated
- Atypical Ductal Hyperplasia
- Contrast enhanced mammography
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 30, 2020
Endometrial Changes in Breast Cancer Women.
Active, not recruiting
- Endometrial Cancer
- +3 more
- Hysteroscopy
-
Rome, Lazio, ItalyIRCCS "Regina Elena" National Cancer Institute
Jan 29, 2023
Breast Tumors, Nipple Discharge Trial in Guangzhou (Magnetic Resonance Ductography (MRD); and High-Resolution Magnetic Resonance
Recruiting
- Breast Neoplasms
- Nipple Discharge
- Magnetic Resonance Ductography (MRD); and High-Resolution Magnetic Resonance Ductography (HR-MRD)
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Apr 1, 2023
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Ductal Carcinoma In Situ Trial in
Not yet recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +3 more
- Biospecimen Collection
- +4 more
-
Houston, Texas
- +2 more
Aug 17, 2022
Breast Tumors, Breast Cancer Trial in Busan, Seoul (Breast MRI for Breast Cancer Detection)
Not yet recruiting
- Breast Neoplasms
- Breast Cancer
- Breast MRI for Breast Cancer Detection
-
Busan, BusanJin-Gu, Korea, Republic of
- +3 more
Apr 2, 2023
Pure Florid and Pleomorphic Lobular Carcinoma in Situ of Breast:
Recruiting
- Pleomorphic Lobular Breast Carcinoma in Situ
- Breast Florid Lobular Carcinoma in Situ
- Surgical wide local excision
- +4 more
-
Padova, ItalyIstituto Oncologico Veneto IRCCS
Nov 14, 2023
Atypical Lesions of Breast: Close Observation Versus Excision
Completed
- Atypical Ductal Hyperplasia (ADH) of the Breast
-
New Haven, ConnecticutYale University & Smilow Breast Center at Yale New Haven Hospita
Jan 25, 2019
Breast Cancer Trial in Fargo, Sioux Falls (Collection of blood)
Recruiting
- Breast Cancer
- Collection of blood
-
Fargo, North Dakota
- +1 more
Nov 9, 2021
Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I Trial in Beijing (statins (oral atorvastatin calcium tablet
Recruiting
- Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
- statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day);
-
Beijing, Beijing, ChinaPeking University People's Hospital
Oct 22, 2023
Atypical Endometrial Hyperplasia, Endometrial Carcinoma Stage I Trial in Peking (Medroxyprogesterone acetate + Atorvastatin)
Recruiting
- Atypical Endometrial Hyperplasia
- Endometrial Carcinoma Stage I
- Medroxyprogesterone acetate + Atorvastatin
-
Peking, Beijing, ChinaWang Jianliu
Dec 29, 2022
Endometrial Atypical Hyperplasia, Endometrial Adenocarcinoma Trial in Shanghai, Hangzhou (Megestrol acetate and metformin,
Completed
- Endometrial Atypical Hyperplasia
- Endometrial Adenocarcinoma
- Megestrol acetate and metformin
- Megestrol acetate
-
Shanghai, Shanghai, China
- +4 more
Sep 10, 2021